Get started
Author

Felipe Casado

Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling
2013 · Alberto J Arribas, Cristina Gómez-Abad, et al. · Modern Pathology · 52
PDF
Clinical and diagnostic relevance of NOTCH2 -and KLF2 -mutations in splenic marginal zone lymphoma
2017 · Yolanda Campos-Martín, Nerea Martínez, et al. · Haematologica · 44
PDF
High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon‐α
2003 · J.L. Steegmann, M.J. Requena, et al. · American Journal of Hematology · 38
PDF
Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
1995 · A. Alegre, M. Lamana, et al. · British Journal of Haematology · 36
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
2018 · On behalf of the CML Spanish Group (GELMC), Santiago Osorio, et al. · Annals of Hematology · 28
Ixazomib Plus Lenalidomide/Dexamethasone (IRd) Versus Lenalidomide /Dexamethasone (Rd) Maintenance after Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Results of the Spanish GEM2014MAIN Trial
2021 · Laura Rosinol, Albert Oriol, et al. · Blood · 25
Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study
2013 · Manuela Mollejo, Javier Menárguez, et al. · Modern Pathology · 24
PDF
Hypertriglyceridemia may be severe in CML patients treated with interferon‐α
1995 · María Jesús Peñarrubia, Juan Luis Steegmann, et al. · American Journal of Hematology · 19
Randomized Phase 2 Study of Weekly Carfilzomib 70 Mg/m2 and Dexamethasone Plus/Minus Cyclophosphamide in Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients (GEM-KyCyDex)
2020 · Maria-Victoria Mateos, Enrique M. Ocio, et al. · Blood · 15
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
2021 · Paula Rodriguez-Otero, Maialen Sirvent, et al. · Clinical Lymphoma Myeloma & Leukemia · 12
Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry
2025 · Ana Alfonso-Pierola, David Martinez-Cuadrón, et al. · Leukemia · 3
OAB-040: BUMEL vs MEL-200 prior autologous transplant for patients with newly diagnosed multiple myeloma previously treated with bortezomib, lenalidomide and dexamethasone: final results of a phase 3 trial
2022 · Juan José Lahuerta Palacios, Ana Jiménez Ubieto, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma
2015 · Francisco Javier Peñalver, Julio Delgado, et al. · European Journal Of Haematology · 2
Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study
2019 · Maria Luisa Lozano, Maria Eva Mingot-Castellano, et al. · Blood · 1
Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up
2019 · Maria Luisa Lozano, Maria Eva Mingot-Castellano, et al. · Blood · 1
Safety and Efficacy of Dasatinib Treatment Change for Patients Previosly Treated with Imatinib with Late Warning Response. Results from the Phase II, Open, Multicenter Dasapost Study
2016 · Valentín García-Gutierrez, Felipe Casado, et al. · Blood · 1
Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry
2015 · Verena Sophia Hoffmann, Michele Baccarani, et al. · Blood · 1
Influence of Age on Survival after a Tandem Hematopoietic Stem Cell Transplantation Procedure in Patients with Multiple Myeloma: Results of the Prospective GEM-2000 Protocol.
2004 · A. Sureda, J. Blade, et al. · Blood · 1
Erythropoietin Treatment and Platelet Reconstitution in Bone Marrow Transplantation
1994 · J. L. Steegmann, F. Casado, et al. · British Journal of Haematology · 1
Drug-associated corneal hypoaesthesia and neurotrophic keratopathy: a disproportionality analysis of FAERS/AEMS
2026 · Calleja-Casado, Francisco · Zenodo (CERN European Organization for Nuclear Research)
Therapeutic strategies in chronic lymphocytic leukemia: efficacy and safety of zanubrutinib in patients with arrhythmias and hemorrhagic risk. Report of two cases
2026 · Felipe Casado, Javier López, et al. · Revista Sangre (ENG)
PDF
Estrategias terapéuticas en LLC: eficacia y seguridad de zanubrutinib en pacientes con arritmias y riesgo hemorrágico. Informe de dos casos
2026 · Felipe Casado, Javier López, et al. · Revista Sangre
PDF
Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study
2019 · Maria Luisa Lozano, Maria Eva Mingot-Castellano, et al. · Blood
Ps1580 Prevalence and Risk Factors for Thrombosis in Adult Itp Patients Treated With Tpo‐ra
2019 · M.L. Lozano, M.E. Mingot, et al. · HemaSphere
Pf690 Predictors of Therapy Free Responses in Itp Patients Receiving Tpo‐ra. Results From a Spanish Multicenter Study
2019 · M.L. Lozano, M.E. Mingot, et al. · HemaSphere
Works count: 29
Citation count: 306
H-index: 10
I10-index: 10
Year
Topic
Type